Provided by Tiger Fintech (Singapore) Pte. Ltd.

GRAIL, Inc.

29.74
+2.8210.48%
Post-market: 29.30-0.4400-1.48%19:54 EDT
Volume:1.41M
Turnover:40.16M
Market Cap:1.01B
PE:-0.47
High:29.75
Open:27.58
Low:26.51
Close:26.92
Loading ...

EU regulators scrap merger power aimed at killer acquisitions after court veto

Reuters
·
30 Nov 2024

Grail 1st-Mover Advantage Faces Regulatory Hurdles in Multi-Cancer Detection, Morgan Stanley Says

MT Newswires Live
·
28 Nov 2024

GRAIL Initiated at Equal-Weight by Morgan Stanley

Dow Jones
·
28 Nov 2024

Morgan Stanley Initiates GRAIL at Equalweight With $16 Price Target

MT Newswires Live
·
27 Nov 2024

Grail initiated with an Equal Weight at Morgan Stanley

TIPRANKS
·
27 Nov 2024

GRAIL to Participate in Upcoming Investor Conferences

PR Newswire
·
20 Nov 2024

GRAIL Says First Person Tested With Blood-Based Assay in Lung Cancer Trial

MT Newswires Live
·
19 Nov 2024

Grail tests first patient for TROPION-Lung12 Phase 3 study

TIPRANKS
·
19 Nov 2024

Grail Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study

THOMSON REUTERS
·
19 Nov 2024

GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study

PR Newswire
·
19 Nov 2024

Stock Market Today: Dow Jones Flat; Tesla Pops On Trump Move, Super Micro Soars As This Key Deadline Looms (Live Coverage)

Blockhead
·
19 Nov 2024

Stock Market Today: Dow Jones Falls; Tesla Pops On Trump Move But Nvidia Skids On AI Chip Worries (Live Coverage)

Blockhead
·
18 Nov 2024

Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now?

Insider Monkey
·
18 Nov 2024

Wolfe Research Initiates GRAIL at Peer Perform

MT Newswires Live
·
15 Nov 2024

Sessa Capital (Master), L.p. Reports 9.66% Passive Stake in Grail as of Sept 30 - SEC Filing

THOMSON REUTERS
·
15 Nov 2024

GRAIL Inc (GRAL) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...

GuruFocus.com
·
15 Nov 2024